about
RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infectionPredictive factors of short term outcome after liver transplantation: A reviewALPPS Procedure for Extended Liver Resections: A Single Centre Experience and a Systematic ReviewTransoesophageal echocardiography during liver transplantationSingle-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat modelPotential therapeutic role of cationic peptides in three experimental models of septic shock.Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides.LL-37 protects rats against lethal sepsis caused by gram-negative bacteriaInteraction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.Metastatic breast cancer mimicking a hilar cholangiocarcinoma: case report and review of the literature.RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureusA chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococciPostoperative Insulin-Like Growth Factor 1 Levels Reflect the Graft's Function and Predict Survival after Liver TransplantationEffects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic RatsCarbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients.Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptidesThe efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infectionDoxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation.Fast track program in liver resection: a PRISMA-compliant systematic review and meta-analysis.Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides.Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: A large retrospective cross-sectional study.Liver transplantation in patients with common variable immunodeficiency: a report of two cases.Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureusEfficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection.Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock.Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron.Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats.Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis.Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model.Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis.Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis.The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
P50
Q24682401-6E2B8845-1F8E-41C3-9EFE-73FDC62B2047Q26741225-35B01BB3-7A67-4CA0-969D-9FC7E988DA42Q26772140-CC6076F3-9387-4BDC-BE41-25DFBD59B2A4Q26781485-1B84F78A-A1FC-433C-94B2-0439E8CAE23BQ34104726-CFD33BF4-E589-453B-8A39-49E36B73092CQ34109677-0C109580-E4F2-4BD0-95C6-E863426DC46DQ34113126-4D3075BE-485C-4639-A4FD-F816FED34E89Q34648782-C53938C0-04FC-42C1-B81C-90A0E627B72DQ34721515-AE12C79A-1321-4600-8DD1-FD1347597281Q34992311-C2FD00A5-3F83-42A4-8EE0-992C76EAB26EQ35013893-6296A1E6-D8FB-468D-835C-5AF9AD7175EFQ35124472-00EF50ED-64A1-447A-B22B-F57F164A0CEBQ35694770-B648CA6F-314E-4C26-86D5-8B3E54FA1772Q35945879-A9C10566-595F-4879-A82B-2C43E7F8E266Q36156964-EAFB5E67-3CB6-461B-BDE7-7E9CFA806095Q36669700-340A490C-7806-4A4C-8A5F-37A94E20759BQ37139168-9C37E267-EF2C-4622-9EBB-61C487DE2C08Q37162432-E03A8C79-D61A-4704-BD8F-2B3F7DD4CAE8Q38840523-2E361CB4-AC14-4C60-BD5F-C196C373CDD5Q40045932-511B3E8F-05D2-4751-80A1-8EADD3870394Q40243056-F07A516F-3343-4BFB-B308-1646BD490EC3Q40313006-3767BC96-F841-4C6B-8022-C9C03269B5E9Q40457245-0C5E7CC8-72BD-43B6-A248-CDD53E7C167EQ41170685-2FC347B1-CEE0-4D34-B837-2EC243575FE9Q41691199-5BC039D9-CD61-42DC-B5A4-C039BAC08172Q41865746-CBCBE4C0-8AE1-4736-9D9C-7D6EC1F11BFFQ42021167-99E96557-7512-424D-80D2-1C3D62966E31Q42237455-D20D3A70-2AAF-46BF-886A-636D50FD596CQ42747673-971A0A6E-EC9C-4F33-B1C1-FD11C4C51997Q42876968-EF499AB7-2053-4EB3-A427-A1DB66FAFF4CQ43506522-BCF3C92A-26FF-4EBF-8596-44C471FF572DQ43685641-CAE23D8C-1E86-47A0-A47F-567C7BDA6FF3Q43991784-43D9FB74-3B14-4BDA-A532-26B17256FAADQ44128915-193AFC24-2C6E-47D7-8ADF-9399BFAB87A3Q44223533-17C18B21-3052-496F-BF95-5A78AFACC484Q44330991-D3E29D92-683F-4CBE-AC78-FFDA256B4817Q44445596-6FBBCD35-BD51-462D-9C57-4EBAE81DDA1EQ44454796-C08DB7E6-CE2F-4773-BCB0-FC9D1BE11377Q44524021-2AEF85D6-D42D-433A-BCEF-F0EC916C78ECQ44529182-C3255AE9-ED1A-4844-A74C-FE887CAA51DC
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Federico Mocchegiani
@ast
Federico Mocchegiani
@en
Federico Mocchegiani
@es
Federico Mocchegiani
@nl
type
label
Federico Mocchegiani
@ast
Federico Mocchegiani
@en
Federico Mocchegiani
@es
Federico Mocchegiani
@nl
prefLabel
Federico Mocchegiani
@ast
Federico Mocchegiani
@en
Federico Mocchegiani
@es
Federico Mocchegiani
@nl
P106
P1153
6701855932
P21
P31
P496
0000-0002-8833-5360